IL312625A - Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions - Google Patents
Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditionsInfo
- Publication number
- IL312625A IL312625A IL312625A IL31262524A IL312625A IL 312625 A IL312625 A IL 312625A IL 312625 A IL312625 A IL 312625A IL 31262524 A IL31262524 A IL 31262524A IL 312625 A IL312625 A IL 312625A
- Authority
- IL
- Israel
- Prior art keywords
- imidazo
- crystalline
- pharmaceutical compositions
- medical conditions
- pyridine compound
- Prior art date
Links
- -1 IMIDAZO[4,5-b]PYRIDINE COMPOUND Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21207942.0A EP4180428A1 (en) | 2021-11-12 | 2021-11-12 | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions |
| PCT/US2022/049695 WO2023086564A1 (en) | 2021-11-12 | 2022-11-11 | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312625A true IL312625A (en) | 2024-07-01 |
Family
ID=78617277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312625A IL312625A (en) | 2021-11-12 | 2022-11-11 | Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11814383B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4180428A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543413A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118843624A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022387516A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3237156A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312625A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024005766A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202334143A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023086564A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9067914B1 (en) * | 2013-12-10 | 2015-06-30 | Genzyme Corporation | Tropomyosin-related kinase (TRK) inhibitors |
| EP4180428A1 (en) | 2021-11-12 | 2023-05-17 | Genzyme Corporation | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions |
| AU2024273547A1 (en) * | 2023-05-17 | 2025-12-04 | Centrexion Therapeutics Corporation | PARTICLES OF IMIDAZO [4,5-b] PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL150524A0 (en) * | 2000-01-07 | 2003-02-12 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| US9067914B1 (en) | 2013-12-10 | 2015-06-30 | Genzyme Corporation | Tropomyosin-related kinase (TRK) inhibitors |
| MA40698A3 (fr) | 2014-12-18 | 2020-01-31 | Genzyme Corp | Formulations pharmaceutiques d'inhibiteurs de kinase associée à la tropomyosine (trk) |
| CA3080157A1 (en) | 2017-10-26 | 2019-05-02 | Array Biopharma Inc. | Formulations of a macrocyclic trk kinase inhibitor |
| EP3773725A1 (en) | 2018-03-29 | 2021-02-17 | Loxo Oncology Inc. | Treatment of trk-associated cancers |
| MX2021001957A (es) | 2018-08-22 | 2021-07-15 | Cullgen Shanghai Inc | Compuestos de degradacion y metodos de uso del receptor de tropomiosina quinasa (trk). |
| BR112022016901A2 (pt) * | 2020-02-26 | 2022-12-06 | Cullgen Shanghai Inc | Compostos de degradação do receptor de tropomiosina quinase (trk) e métodos de uso |
| EP4180428A1 (en) | 2021-11-12 | 2023-05-17 | Genzyme Corporation | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions |
-
2021
- 2021-11-12 EP EP21207942.0A patent/EP4180428A1/en not_active Withdrawn
-
2022
- 2022-11-11 MX MX2024005766A patent/MX2024005766A/es unknown
- 2022-11-11 JP JP2024527604A patent/JP2024543413A/ja active Pending
- 2022-11-11 US US17/985,531 patent/US11814383B2/en active Active
- 2022-11-11 EP EP22893662.1A patent/EP4430043A4/en active Pending
- 2022-11-11 WO PCT/US2022/049695 patent/WO2023086564A1/en not_active Ceased
- 2022-11-11 TW TW111143263A patent/TW202334143A/zh unknown
- 2022-11-11 CA CA3237156A patent/CA3237156A1/en active Pending
- 2022-11-11 AU AU2022387516A patent/AU2022387516A1/en active Pending
- 2022-11-11 CN CN202280087913.4A patent/CN118843624A/zh active Pending
- 2022-11-11 IL IL312625A patent/IL312625A/en unknown
-
2023
- 2023-11-09 US US18/505,713 patent/US12291528B2/en active Active
-
2025
- 2025-04-22 US US19/185,943 patent/US20250250274A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202334143A (zh) | 2023-09-01 |
| US11814383B2 (en) | 2023-11-14 |
| US20240150352A1 (en) | 2024-05-09 |
| US12291528B2 (en) | 2025-05-06 |
| EP4180428A1 (en) | 2023-05-17 |
| JP2024543413A (ja) | 2024-11-21 |
| US20230151008A1 (en) | 2023-05-18 |
| MX2024005766A (es) | 2024-07-29 |
| US20250250274A1 (en) | 2025-08-07 |
| AU2022387516A1 (en) | 2024-05-23 |
| EP4430043A1 (en) | 2024-09-18 |
| EP4430043A4 (en) | 2025-11-05 |
| WO2023086564A1 (en) | 2023-05-19 |
| CA3237156A1 (en) | 2023-05-19 |
| CN118843624A (zh) | 2024-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289164A (en) | The history of imidazo[2,1-a)pyridinyl and their use in the treatment of diseases | |
| CA3261509A1 (en) | CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY | |
| MY150216A (en) | Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile | |
| IL196243A (en) | [4,2,1] Triazole [3,4– a Pyridine Derivatives | |
| IL288872B1 (en) | IMIDAZO[1,5-c]PYRIMIDIN-5-AMINE PERI-CONDENSED DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USES IN CANCER TREATMENT | |
| IL172192A0 (en) | Pyridino [1,2 - a] pyrimidin - 4 - one compounds as anticancer agents | |
| MX340533B (es) | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. | |
| IL201977A (en) | 6- (Pyrrolidine-3-Yl) -Pyrazolo [4,3- d] Pyrimidine-4-Ones, Pharmaceuticals Including Them and Their Use in the Preparation of Medicines to Treat Diseases | |
| MY148583A (en) | Pyridine [3,4-b] pyrazinones | |
| ZA201307631B (en) | 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections | |
| MX2015002177A (es) | Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas. | |
| UA94901C2 (ru) | Антибактериальные производные пиперидина | |
| ZA201200705B (en) | Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation | |
| WO2021009676A8 (en) | Imidazo[4,5-c]pyridine derivatives as toll-like receptor agonists | |
| WO2006126082A3 (en) | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors | |
| EP4430043A4 (en) | IMIDAZO[4,5-b]PYRIDINE CRYSTALLINE COMPOUND, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS | |
| MX2009012109A (es) | Composiciones contra el insomnio y metodos. | |
| IL206673A0 (en) | Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application | |
| SG10201809189UA (en) | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, salts thereof and methods of use | |
| EP4516318A3 (en) | 1-isopropyl-3-methyl-8- (pyridin-3-yl) -1, 3-dihydro-2h-imidazo [4, 5-c] cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof | |
| IL217294A (en) | History 3,2 - Dihydro - 1h - Imidazo [1, 2 - a] - Pyrimidin - 5 - On, process for their preparation, pharmaceutical preparations containing them and their use in the preparation of medicines | |
| EP2583962A4 (en) | NOVEL THIOURED OR NEW UREA DERIVATIVE, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS, CONTAINING THE SAME AS ACTIVE INGREDIENT | |
| WO2007071965A3 (en) | Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines | |
| IL206669A0 (en) | 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | |
| CA3292405A1 (en) | PARTICLES OF IMIDAZO [4,5-b] PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONS |